FDA Inspection 1144543 — Advarra IRB
The FDA completed an inspection of Advarra IRB on May 27, 2021 in Columbia, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 27, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Columbia, MD (United States)
Additional Details
IRB